,Unnamed: 0,symbol,name_of_company,series,date_of_listing,isin_number,industry_key,sector_key,macro,basic_industry,previous_close,open,day_low,day_high,regular_market_previous_close,regular_market_open,regular_market_day_low,regular_market_day_high,volume,regular_market_volume,average_volume,average_volume10days,average_daily_volume10_day,fifty_two_week_low,fifty_two_week_high,fifty_day_average,two_hundred_day_average,current_price,52_week_change,sand_p52_week_change,price_hint,debt_to_equity,quick_ratio,current_ratio,float_shares,shares_outstanding,implied_shares_outstanding,held_percent_insiders,compensation_as_of_epoch_date,ex_dividend_date,last_dividend_value,last_dividend_date,last_split_factor,last_split_date,payout_ratio,paid_up_value,market_lot,face_value,market_cap,enterprise_value,total_cash,total_cash_per_share,total_debt,total_revenue,revenue_per_share,ebitda,free_cashflow,operating_cashflow,book_value,price_to_book,price_to_sales_trailing12_months,enterprise_to_revenue,enterprise_to_ebitda,earnings_growth,revenue_growth,earnings_quarterly_growth,net_income_to_common,trailing_eps,forward_eps,trailing_pe,profit_margins,gross_margins,ebitda_margins,operating_margins,return_on_assets,return_on_equity,long_business_summary,beta,recommendation_key,market_cap_rank
26,26,GILLANDERS,Gillanders Arbuthnot & Company Limited,EQ,14-DEC-2009,INE047B01011,farm-products,consumer-defensive,Fast Moving Consumer Goods,Tea & Coffee,88.24,88.92,87.15,90.88,88.24,88.92,87.15,90.88,11622.0,11622.0,26179.0,11738.0,11738.0,70.0,159.8,89.5146,96.36315,87.36,0.11766946,0.2573837,2.0,59.417,,,5801063.0,21342300.0,21589000.0,0.70912004,1735603200.0,1407196800.0,0.75,1407196800.0,3:2,1284422400.0,,10.0,1,10,188.6015104,3132629248.0,23887000.0,1.119,1292049024.0,3604581120.0,168.942,-27149000.0,,,101.888,0.85741204,0.5232273,0.869,-115.387,,-0.032,,-531854016.0,-24.92,,,-0.14755,0.70171,-0.00753,-0.09358,,,"Gillanders Arbuthnot and Company Limited engages in the textile, engineering, tea, and property businesses in India and internationally. The company's Textile segment manufactures and sells yarns in cotton, acrylic, polyster, viscose, staple, and blends. Its Engineering segment manufactures and sells steel structural, pipes, and equipment; and engages in the designing, supplying, erectioning, and commissioning of projects on turnkey basis. The company's Tea segment manufactures and sells tea. Its Property segment is involved in letting out properties on rent. The company was incorporated in 1935 and is based in Kolkata, India.",0.961,none,1722.0
72,72,EASEMYTRIP,Easy Trip Planners Limited,EQ,19-MAR-2021,INE07O001026,travel-services,consumer-cyclical,Consumer Discretionary,Tour Travel Related Services,41.09,41.23,41.0,42.38,41.09,41.23,41.0,42.38,14314013.0,14314013.0,15592399.0,27765141.0,27765141.0,37.0,54.0,40.5368,43.54395,41.98,0.028535724,0.2573837,2.0,3.117,,,548340249.0,1772039936.0,1773740032.0,0.66757005,1703980800.0,1702944000.0,0.1,1702944000.0,4:1,1668988800.0,0.16129999,1.0,1,1,7439.0233088,72858312704.0,1927980032.0,1.088,194700000.0,6191260160.0,3.539,2248647424.0,,,3.411,12.307241,12.015362,11.768,32.401,0.267,0.23,0.248,1095660032.0,0.62,,67.70968,0.17697,0.73417,0.3632,0.39826,,,"Easy Trip Planners Limited, together with its subsidiaries, operates as an online travel agency in India, the Philippines, Singapore, Thailand, the United Arab Emirates, the United Kingdom, New Zealand, and the United States. The company provides reservation and booking services related to travel and tourism through ease-my-trip portal and app or in-house call centre, which includes a range of travel-related products and services, such as airline tickets, hotels, and holiday and travel packages; and train tickets, bus tickets, air charter services, and cab bookings. It also offers travel guides and updates, and other reservation activities. The company was incorporated in 2008 and is based in New Delhi, India.",0.212,none,627.0
208,208,SAKAR,Sakar Healthcare Limited,EQ,11-APR-2019,INE732S01012,drug-manufacturers-specialty-generic,healthcare,Healthcare,Pharmaceuticals,332.3,334.0,333.45,347.95,332.3,334.0,333.45,347.95,45058.0,45058.0,29630.0,36799.0,36799.0,295.15,479.0,323.356,359.0975,339.3,0.019325137,0.2573837,2.0,30.249,,,21927053.0,17118000.0,17253900.0,,,,,,,,,10.0,1,10,580.8137216,8075293696.0,4656000.0,0.212,793516992.0,1555106048.0,72.971,402639008.0,,,122.73,2.764605,3.7348819,5.193,20.056,-0.253,0.055,-0.151,112426000.0,5.25,,64.62857,0.07229,0.45619,0.25891,0.1371,,,"Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.",0.402,none,1432.0
248,248,SANOFI,Sanofi India Limited,BE,19-MAY-2003,INE058A01010,drug-manufacturers-general,healthcare,Healthcare,Pharmaceuticals,7223.0,7237.0,7134.05,7237.0,7223.0,7237.0,7134.05,7237.0,10319.0,10319.0,20043.0,23767.0,23767.0,5892.8,10524.95,6714.431,7905.319,7156.1,0.005813718,0.2573837,2.0,3.228,0.669,1.371,9078191.0,23030600.0,23037200.0,0.60582,1703980800.0,1714694400.0,117.0,1714694400.0,,,0.72730005,10.0,1,10,16480.927744,162548088832.0,2481999872.0,107.77,221000000.0,27893000192.0,1211.097,7776000000.0,3393625088.0,3315000064.0,297.257,24.073782,5.908625,5.828,20.904,-0.16,-0.344,-0.16,5288000000.0,229.69,252.83,31.15547,0.1898,0.57226,0.27878,0.23020001,0.32641998,0.75071,"Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. It also exports its products to approximately 35 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.",0.296,buy,402.0
510,510,SREEL,Sreeleathers Limited,EQ,01-JAN-2014,INE099F01013,footwear-accessories,consumer-cyclical,Consumer Discretionary,Footwear,290.55,292.1,286.35,294.5,290.55,292.1,286.35,294.5,23959.0,23959.0,27026.0,16033.0,16033.0,230.0,433.7,300.747,313.68875,289.2,0.20710433,0.2573837,2.0,0.703,,,5425127.0,23155000.0,23388100.0,0.77962,,1410998400.0,0.25,1410998400.0,,,,10.0,1,10,669.6426496,6617797632.0,105285000.0,4.549,29338000.0,2167386880.0,93.57,352696736.0,,,180.026,1.6064347,3.0896313,3.053,18.763,-0.289,-0.019,-0.289,249714000.0,10.78,7.78,26.82746,0.11521,0.24719,0.16273001,0.13099,,,"Sreeleathers Limited engages in the wholesale and retail of footwear and accessories in India. The company offers formal, canvas, and casual, as well as school shoes; chappals; sandals; and accessories, such as belts, wallets, bags, socks, and jewelry and watch boxes for men, women, and kids. It sells its products through online. The company was formerly known as CAT Financial Services Ltd and changed its name to Sreeleathers Limited in October 2010. Sreeleathers Limited was incorporated in 1991 and is based in Kolkata, India.",0.327,none,1389.0
